Immunostaining for EPO in post-treatment surgical specimens demonstrated a strong staining in tumor cells compared to a faint positivity in cirrhotic nodules (Fig. 2), suggesting that the tumor was the source of increased EPO production. The gene discussed is EPO; the disease is neoplasm.